BioPharm International-02-01-2003

BioPharm International

Becoming a Partner of Choice and Evaluating Prospective Alliances

February 15, 2003

Focus on Contract Services

16

2

by David Wallis, Dechert and Jan Heybroek Whether you're on the inlicensing or outlicensing side of a collaboration, attention must be paid to putting forth the right image and learning about your prospective partners before the alliance is struck.

Using Amino Acid Analysis to Determine Absorptivity Constants: A Validation Case Study Using Bovine Serum Albumin

February 15, 2003

Articles

16

2

by John C. Anders, aaiPharma, Inc., Benne F. Parten, Glenn E. Petrie , Robert L. Marlowe , and John E. McEntire Amino acid analysis (AAA) of well-recovered residues offers an easy way to calculate the absorptivity constant for a known protein. The method provides an absolute measure of protein concentration, free from interference from water, excipients, and bound salts. This article demonstrates a qualified method for determining protein content by AAA.

Guest Editorial: Maybe You Need a Corporate Marriage Counselor

February 15, 2003

Columns and Departments

16

2

by Jay R. Greenwald, Unisys

Inside Washington: AIDS Prevention Campaign Spotlights Biotech

February 15, 2003

Columns and Departments

16

2

by Jill Wechsler Efforts to move vaccines from test stage to commercial production are raising concerns about manufacturing capacity.

The Double Helix at 50: A Half Century of Innovation in the Words of Eight Distinguished Scientists

February 15, 2003

Articles

16

2

by Patrick Clinton , BioPharm International A BioPharm International Forum

Survival Strategies: Keeping Tabs on Training

February 15, 2003

Columns and Departments

16

2

by Vicki Cloutier, Guidant Corporation It's not enough to train your staff ? you have to keep training them. A good learning management system can help.

Biotech World: Contract Manufacturing: Diversity in the European Marketplace

February 15, 2003

Columns and Departments

16

2

by David Venables, Q-One Biotech Ltd. Approximately 75 vendors offer biological contract manufacturing services in Europe ? a manageable data set for analyzing the services they provide.

Outsourcing Outlook: Contract Services' Crystal Ball

February 15, 2003

Columns and Departments

16

2

by Jim Miller, Bio/Pharmaceutical Outsourcing Report Developments in 2002 such as acquisitions, excess manufacturing capacity, and less funding for biotechnology will continue to affect the industry long into the new year.

Virus Inactivation in the 1990s ? and into the 21st Century: Part 5: Disinfection

February 15, 0003

Articles

16

2

by Gail Sofer, BioReliance Both the process and the product strongly influence viral inactivation, and unknown or unspecified details ? such as variability in virus titers, measuring devices, calibrations, and protocols ? can all influence log reduction values. This article series covers what you need to know to fully understand the properties of the test article, the viruses inactivated, and the critical control parameters for selected inactivation methods.